Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M212670200 on March 13, 2003

J. Biol. Chem., Vol. 278, Issue 21, 19272-19279, May 23, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/21/19272    most recent
M212670200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hotchkiss, K. A.
Right arrow Articles by Schwartz, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hotchkiss, K. A.
Right arrow Articles by Schwartz, E. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Thymidine Phosphorylase and 2-Deoxyribose Stimulate Human Endothelial Cell Migration by Specific Activation of the Integrins {alpha}5{beta}1 and {alpha}V{beta}3*

Kylie A. Hotchkiss {ddagger}, Anthony W. Ashton § and Edward L. Schwartz {ddagger} ¶

From the {ddagger} Department of Oncology, Albert Einstein College of Medicine, Bronx, New York 10467, § Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, New York 10467

Thymidine phosphorylase is an angiogenic factor that is frequently overexpressed in solid tumors, in rheumatoid arthritis, and in response to inflammatory cytokines. Our previous studies showed that cells expressing thymidine phosphorylase stimulated endothelial cell migration in vitro. This was a consequence of the intracellular metabolism of thymidine by thymidine phosphorylase and subsequent extracellular release of 2-deoxyribose. The mechanisms by which 2-deoxyribose might mediate thymidine phosphorylase-induced cell migration in vitro, however, are obscure. Here we show that both thymidine phosphorylase and 2-deoxyribose stimulated the formation of focal adhesions and the tyrosine 397 phosphorylation of focal adhesion kinase in human umbilical vein endothelial cells. Although similar actions occurred upon treatment with the angiogenic factor vascular endothelial growth factor (VEGF), thymidine phosphorylase differed from VEGF in that its effect on endothelial cell migration was blocked by antibodies to either integrin {alpha}5{beta}1 or {alpha}v{beta}3, whereas VEGF-induced endothelial cell migration was only blocked by the {alpha}v{beta}3 antibody. Further, thymidine phosphorylase and 2-deoxyribose, but not VEGF, increased the association of both focal adhesion kinase and the focal adhesion-associated protein vinculin with integrin {alpha}5{beta}1 and, in intact cells, increased the co-localization of focal adhesion kinase with {alpha}5{beta}1. Thymidine phosphorylase and 2-deoxyribose-induced focal adhesion kinase phosphorylation was blocked by the antibodies to {alpha}5{beta}1 and {alpha}v{beta}3, directly linking the migration and signaling components of thymidine phosphorylase and 2-deoxyribose action. Cell surface expression of {alpha}5{beta}1 was also increased by thymidine phosphorylase and 2-deoxyribose. These experiments are the first to demonstrate a direct effect of thymidine phosphorylase and 2-deoxyribose on signaling pathways associated with endothelial cell migration.


Received for publication, December 12, 2002 , and in revised form, February 6, 2003.

To whom correspondence should be addressed: Dept. of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, 111 E. 210th St., Bronx, NY 10467. Tel.: 718-920-4015; Fax: 718-882-4464; E-mail: eschwart{at}aecom.yu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol Cancer ResHome page
E. J. Yu, Y. Lee, S. Y. Rha, T. S. Kim, H. C. Chung, B. K. Oh, W. I. Yang, S. H. Noh, and H.-C. Jeung
Angiogenic Factor Thymidine Phosphorylase Increases Cancer Cell Invasion Activity in Patients with Gastric Adenocarcinoma
Mol. Cancer Res., October 1, 2008; 6(10): 1554 - 1566.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zou, Y. Chen, Y. Jiang, J. Gao, and J. Gu
Targeting Matrix Metalloproteinases and Endothelial Cells with a Fusion Peptide against Tumor
Cancer Res., August 1, 2007; 67(15): 7295 - 7300.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Liekens, A. Bronckaers, A.-I. Hernandez, E.-M. Priego, E. Casanova, M.-J. Camarasa, M.-J. Perez-Perez, and J. Balzarini
5'-O-Tritylated Nucleoside Derivatives: Inhibition of Thymidine Phosphorylase and Angiogenesis
Mol. Pharmacol., August 1, 2006; 70(2): 501 - 509.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Lu, J. Murtagh, and E. L. Schwartz
The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere)
Mol. Pharmacol., April 1, 2006; 69(4): 1207 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. W. Ashton and J. A. Ware
Thromboxane A2 Receptor Signaling Inhibits Vascular Endothelial Growth Factor-Induced Endothelial Cell Differentiation and Migration
Circ. Res., August 20, 2004; 95(4): 372 - 379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Liekens, A.-I. Hernandez, D. Ribatti, E. De Clercq, M.-J. Camarasa, M.-J. Perez-Perez, and J. Balzarini
The Nucleoside Derivative 5'-O-Trityl-inosine (KIN59) Suppresses Thymidine Phosphorylase-triggered Angiogenesis via a Noncompetitive Mechanism of Action
J. Biol. Chem., July 9, 2004; 279(28): 29598 - 29605.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Nakajima, T. Gotanda, H. Uchimiya, T. Furukawa, M. Haraguchi, R. Ikeda, T. Sumizawa, H. Yoshida, and S.-i. Akiyama
Inhibition of Metastasis of Tumor Cells Overexpressing Thymidine Phosphorylase by 2-Deoxy-L-Ribose
Cancer Res., March 1, 2004; 64(5): 1794 - 1801.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. H. Zhu and E. L. Schwartz
Expression of the Angiogenic Factor Thymidine Phosphorylase in THP-1 Monocytes: Induction by Autocrine Tumor Necrosis Factor-{alpha} and Inhibition by Aspirin
Mol. Pharmacol., November 1, 2003; 64(5): 1251 - 1258.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement